Michael J. Thorpy, MB, ChBProfessor
*Identify signs and symptoms of excessive daytime sleepiness (EDS) in patients with narcolepsy.
*Outline currently available pharmacologic therapies for treating patients with EDS due to narcolepsy.
*Review key clinical trial data on available pharmacologic therapies for treating patients with EDS due to narcolepsy.
Patients with narcolepsy experience disruptions in their sleep-wake cycles, which may manifest as a syndrome known as EDS. EDS can be significantly disabling to affected individuals, causing social and occupational impairment. A significant economic burden may result from increased health care utilization as well. Therefore, it is critical for clinicians to be adept at recognizing, diagnosing, and managing EDS in their patients with narcolepsy. Here, we provide a case-based module that takes clinicians through the entire management spectrum for EDS in narcolepsy, beginning from diagnosis to initial selection of therapy and monitoring of therapeutic response for successful outcomes.
This event is sponsored by Clinical Care Solutions and is not sponsored by industry.